EUR/USD 1.12248
-0.007%
Gold 3316.27
0.314%
Oil 59.874
-0.082%
USD/JPY 145.535
-0.267%
GBP/USD 1.32301
-0.113%
GBP/JPY 192.550
-0.348%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On May 9, Ruipu Lanjuns PHEV series 54Ah battery cell products were the first to pass the new national standard certification ("GB38031-2025 Safety Requirements for Power Batteries for Electric Vehicles"), making Ruipu Lanjun one of the first companies in the industry to meet the standards.TSMC (TSM.N) shares rose nearly 3% in overnight trading in the U.S.TSMC (TSM.N): Consolidated revenue in April 2025 was approximately NT$349.567 billion, an increase of 22.2% from the previous month and 48.1% from the same period last year. Cumulative revenue from January to April 2025 was approximately NT$1.188821 trillion, an increase of 43.5% from the same period last year.Futures News, May 9, Economies.com analysts latest views today: Spot gold has risen slightly in recent trading. Previously, its price relied on the support of the short-term bullish trend line, showing positive momentum, especially after the relative strength index (RSI) showed a bullish crossover signal, and it has reached an oversold level, further enhancing the markets bullish expectations.Futures May 9, Economies.com analysts latest view today: WTI crude oil futures prices rose in the upcoming intraday trading, affected by the breakthrough of the main bearish trend line in the short term, and its price is still running above its EAM50, which represents the dynamic support for future trading, trying to break through the current key resistance level of 59.65 to announce the continuation of the bullish correction trend. On the other hand, we noticed a negative overlapping signal on the (RSI) indicator, which may weaken the price gains after reaching the overbought level.

Walmart And CVS Will Stop Processing Restricted Drug Prescriptions Written by Cerebral, Done

Aria Thomas

May 26, 2022 09:34

W1.png


Walmart (NYSE:WMT) Inc and CVS Health Corp (NYSE:CVS) announced on Wednesday that they will cease processing restricted drug prescriptions written by telehealth firms Cerebral Inc and Done Health.


Cerebral and Done are well-known for treating ADHD patients with stimulants like Adderall.


Walmart told Reuters that the decision was taken following an audit and compliance procedure.


CVS announced on May 26 that it will no longer accept restricted drug prescriptions provided by the startups, as a consequence of an investigation it did on the telehealth companies and its inability to "resolve issues we have with Cerebral and Done Health."


The Wall Street Journal was the first to announce the news early on Wednesday.


Cerebral and Done declined to comment when contacted by Reuters.


Federal prosecutors reportedly filed a subpoena to Cerebral earlier this month as part of a probe into suspected breaches of the Controlled Substances Act.


The WSJ was the first to publish the news on Wednesday.

Suggestion